Orbimed Advisors Llc bought $12.5M of Prelude Therapeutics (PRLD)

Executed Apr 21, disclosed Apr 23, 2 days later.

Value, as filed

$12.5M

2,815,315 sh across 2 lots

Executed

Apr 21

the trade date, as filed

Disclosed

Apr 23

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+0.0%

-9.0% from execution

Over the 21 trading sessions from the disclosed entry session (Apr 23), the stock returned +0.0% (delay-adjusted); from the execution session (Apr 21), -9.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

OL Orbimed Advisors Llc Director profile →

Orbimed Advisors Llc (Director) filed 15 Form 4 reports as a reporting entity in the trailing twelve months (7 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Sionna Therapeutics, Inc. (SION). Across 7 priced purchase filings, the average 21-session return was +16.9% from execution and +18.9% from disclosure (delay-adjusted; derived). The largest single filing was $38.9M of ELVN (858,646 sh across 3 lots, as filed), executed Jun 22.

The name

PRLD PRLD PRLD · 3 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→